Pathophysiologic bases for adjunctive therapies in the treatment and secondary prevention of acute myocardial infarction.
Clin Cardiol
; 21(3): 161-8, 1998 Mar.
Article
em En
| MEDLINE
| ID: mdl-9541759
ABSTRACT
Postmyocardial infarction (MI) survival has been steadily improving. This improvement has been due, in part, to the actions of the adjunctive medical therapies for the treatment of MI. Aspirin, beta blockers, angiotensin-converting enzyme (ACE) inhibitors, and lipid-lowering agents have been shown to improve survival in the treatment and secondary prevention of MI. Nitrates have beneficial effects as well. These medications complement the reperfusion strategies through different mechanisms. Other adjunctive medical therapies, namely magnesium, antiarrhythmic agents, and calcium-channel blockers, have not been shown to improve mortality with routine post-MI use despite their theoretical benefits.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Infarto do Miocárdio
Limite:
Humans
Idioma:
En
Revista:
Clin Cardiol
Ano de publicação:
1998
Tipo de documento:
Article
País de afiliação:
Estados Unidos